United Kingdom· GB-APID-23070811000001106
Tafinlar 75mg capsules
A dabrafenib product containing dabrafenib, registered in United Kingdom by Novartis Pharmaceuticals UK Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Dabrafenib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EC02 (dabrafenib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Dabrafenib · ATC L01EC02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dabrafenib costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dabrafenib · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$232.39
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Dabrafenib
- Manufacturer
- Novartis Pharmaceuticals UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EC02
- ATC class
- Dabrafenib
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5000123114092
- gtin7613421024383
- gtin7613421105310
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
522 interactions on record for dabrafenib.
Graded by severity as the source publishes them — 79 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dabrafenib · interactions on record
522 records
- 79 severe
- 430 moderate
- 13 minor
Most severe, free to view
- LonafarnibA16AX20severe
- AvatrombopagB02BX08severe
- VoxelotorB06AX03severe
- RanolazineC01EB18severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dabrafenib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTafinlarNovartis Europharm Limited
- CzechiaTAFINLARNovartis Europharm Limited, Dublin
- SwitzerlandTafinlar 75 mg, HartkapselnNovartis Pharma Schweiz AG
- FranceTAFINLAR 75 mg, géluleNOVARTIS EUROPHARM (IRLANDE)
- IrelandTafinlar 75 mg hard capsulesNovartis Europharm Limited
- IcelandTafinlarNovartis Europharm Limited*
- NetherlandsTafinlar 75 mg, harde capsulesNovartis Europharm Limited
- NorwayTafinlarNovartis Europharm Limited (1)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Finlee, Tafinlar
- Liechtenstein · Finlee, Tafinlar
- Norway · Finlee, Tafinlar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/841aecc5-cf13-4f06-9abf-0ab7f64a54e7 GET /v1/drugs/841aecc5-cf13-4f06-9abf-0ab7f64a54e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "23070811000001106",
"desc": "Tafinlar 75mg capsules (Novartis Pharmaceuticals UK Ltd)",
"form": "Oral capsule",
"vpid": "41761011000001106",
"source": "dmd",
"vtm_id": "775432006",
"strength": "75 mg",
"substance": "Dabrafenib",
"ingredient": "Dabrafenib mesilate",
"supplier_code": "2920101000001102"
}See everything about dabrafenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.